FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to functional diagnostics, public health and health care, and can be used to assess the severity of light desynchronosis. A total assessment is carried out on a five-point scale, which is characterized by the following actions on patients over 45 years old. Evaluate the ratio of the evening value of the level of total blood cholesterol to the morning value; if the value is greater than one, 1 point is awarded. It is necessary to find the ratio of evening values of low-density lipoproteins to high density lipoproteins, with a value greater than 1.75, 1 point is awarded. The level of the evening value of blood plasma malondialdehyde is estimated, with a value of more than 1.3 mcM/l, 1 point is awarded. On the Beck depression scale, the level of depression is determined, with a value of more than 20, 1 point is awarded, then the ratio of the phase of the circadian rhythm of the axillary temperature determined by cosinor analysis and the patient's age at the time of the study is determined, with a value of more than 0.25 hours/years 1 point is assigned. According to the total assessment of the number of points, the severity of light desynchronosis is determined: high - with a value of 4 to 5 points inclusive, medium - with a value of 3 points, low - with a value of 1 to 2 points inclusive.
EFFECT: invention allows determining the high, medium and low severity of light desynchronosis.
1 cl, 4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING INDIVIDUAL METABOLIC RISK BY CIRCADIAN LIGHT HYGIENE USING ACTIGRAPHY | 2024 |
|
RU2830419C1 |
METHOD FOR QUANTITATIVE ASSESSMENT OF CIRCADIAN EQUILIBRIUM ACCORDING TO ACTIGRAPHY DATA | 2024 |
|
RU2834158C1 |
METHOD FOR ASSESSING INDIVIDUAL METABOLIC RISK BY CIRCADIAN LIGHT HYGIENE | 2024 |
|
RU2828989C1 |
METHOD FOR ASSESSING THE CHRONOARCHITECTONICS OF VASCULAR WALL TENSION | 2020 |
|
RU2761743C1 |
METHOD FOR INTEGRATIVE ASSESSMENT OF SLEEP IN ACTIGRAPHY | 2024 |
|
RU2833895C1 |
METHOD FOR DETERMINING BLOOD TRIGLYCERIDES TAKING INTO ACCOUNT BIOLOGICAL CLOCK PHASE | 2024 |
|
RU2834162C1 |
METHOD FOR ASSESSING THE RISK OF CERTAIN DISEASES OF THE RESPIRATORY SYSTEM BASED ON THE AVERAGE ADJUSTED SLEEP PHASE ACCORDING TO THE MUNICH TEST | 2022 |
|
RU2781888C1 |
METHOD FOR ESTIMATING THE RISK OF OCCURRENCE OF PSYCHOLOGICAL SLEEP AND MOOD DISORDERS BASED ON THE ADJUSTED AVERAGE SLEEP STAGE ACCORDING TO THE MUNICH QUESTIONNAIRE | 2021 |
|
RU2762914C1 |
METHOD FOR ASSESSING THE RISK OF TYPE 2 DIABETES MELLITUS BASED ON THE AVERAGE ADJUSTED SLEEP PHASE ACCORDING TO THE MUNICH TEST | 2022 |
|
RU2786822C1 |
METHOD FOR ASSESSING THE RISK OF DEVELOPING DISEASES OF THE CARDIOVASCULAR SYSTEM BASED ON THE AVERAGE ADJUSTED SLEEP PHASE ACCORDING TO THE MUNICH TEST | 2022 |
|
RU2786829C1 |
Authors
Dates
2021-05-28—Published
2020-12-29—Filed